You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
AstraZeneca
Express Scripts
McKinsey
Moodys

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Rising Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?

RISING has thirty-four approved drugs.



Summary for Rising
US Patents:0
Tradenames:31
Ingredients:31
NDAs:34
Patent Litigation for Rising: See patent lawsuits for Rising

Drugs and US Patents for Rising

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising DESOXIMETASONE desoximetasone GEL;TOPICAL 204675-001 Aug 12, 2016 AB RX No No   Start Trial   Start Trial
Rising PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 205464-001 Aug 15, 2017 AB RX No No   Start Trial   Start Trial
Rising DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 201518-002 Sep 9, 2016 AB RX No No   Start Trial   Start Trial
Rising TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206309-005 Apr 27, 2016 AB RX No No   Start Trial   Start Trial
Rising TEMOZOLOMIDE temozolomide CAPSULE;ORAL 206309-002 Apr 27, 2016 AB RX No No   Start Trial   Start Trial
Rising CROMOLYN SODIUM cromolyn sodium CONCENTRATE;ORAL 202583-001 Oct 27, 2011 AA RX No No   Start Trial   Start Trial
Rising LEVOFLOXACIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 077700-001 Dec 20, 2010 AT RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Baxter
McKesson
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.